Power to the Patients podcast

70% Remission for Postpartum Depression? The Psychedelic Breakthrough

0:00
35:54
Rewind 15 seconds
Fast Forward 15 seconds
Postpartum depression treatment advances with psychedelic therapy. Greg Mayes of Reunion Neuroscience discusses luvesilocin drug development. This episode explores how shorter-acting psilocybin analogs offer new hope for mothers. Greg highlights the success of the RECONNECT study and the path to FDA breakthrough designation.

More episodes from "Power to the Patients"